(AFRM) Affirm Holdings - Ratings and Ratios
Point-Of-Sale, Installment, Merchant, App, Consumer
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 79.9% |
| Value at Risk 5%th | 117% |
| Relative Tail Risk | -11.07% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.75 |
| Alpha | -10.63 |
| CAGR/Max DD | 1.38 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.353 |
| Beta | 2.414 |
| Beta Downside | 2.477 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.38% |
| Mean DD | 24.30% |
| Median DD | 23.37% |
Description: AFRM Affirm Holdings December 17, 2025
Affirm Holdings, Inc. (NASDAQ: AFRM) operates a U.S.-based payment network that extends to Canada and other international markets, offering a point-of-sale financing solution, merchant commerce tools, and a consumer-facing app that lets shoppers split purchases into installments.
In FY 2023 the company reported roughly $1.5 billion in revenue and processed about $15 billion in total payment volume, reflecting a year-over-year growth rate near 20 % despite a net loss of $300 million as it invests in technology and expands its merchant base.
The buy-now-pay-later (BNPL) sector is being shaped by a 12 % CAGR in consumer demand, tighter credit conditions from rising interest rates, and intensifying competition from both fintechs and traditional card issuers-all of which directly affect Affirm’s pricing power and merchant adoption rates.
For a deeper quantitative dive into AFRM’s risk-adjusted valuation, you might explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (233.1m TTM) > 0 and > 6% of Revenue (6% = 207.6m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 2.95pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 67.55% (prev 343.1%; Δ -275.5pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 971.6m > Net Income 233.1m (YES >=105%, WARN >=100%) |
| Net Debt (6.53b) to EBITDA (917.8m) ratio: 7.11 <= 3.0 (WARN <= 3.5) |
| Current Ratio 14.61 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (348.3m) change vs 12m ago 9.44% (target <= -2.0% for YES) |
| Gross Margin 67.62% (prev 65.71%; Δ 1.92pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 32.00% (prev 24.90%; Δ 7.10pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.56 (EBITDA TTM 917.8m / Interest Expense TTM 431.3m) >= 6 (WARN >= 3) |
Altman Z'' 0.52
| (A) 0.20 = (Total Current Assets 2.51b - Total Current Liabilities 171.7m) / Total Assets 11.48b |
| (B) -0.26 = Retained Earnings (Balance) -2.98b / Total Assets 11.48b |
| (C) 0.06 = EBIT TTM 674.1m / Avg Total Assets 10.81b |
| (D) -0.37 = Book Value of Equity -3.00b / Total Liabilities 8.18b |
| Total Rating: 0.52 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.21
| 1. Piotroski 4.0pt |
| 2. FCF Yield 2.30% |
| 3. FCF Margin 22.24% |
| 4. Debt/Equity 2.41 |
| 5. Debt/Ebitda 7.11 |
| 6. ROIC - WACC (= -5.59)% |
| 7. RoE 7.75% |
| 8. Rev. Trend 97.60% |
| 9. EPS Trend 77.67% |
What is the price of AFRM shares?
Over the past week, the price has changed by -5.46%, over one month by +13.59%, over three months by +4.39% and over the past year by +39.68%.
Is AFRM a buy, sell or hold?
- Strong Buy: 11
- Buy: 6
- Hold: 7
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the AFRM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 92.6 | 21.2% |
| Analysts Target Price | 92.6 | 21.2% |
| ValueRay Target Price | 79.8 | 4.4% |
AFRM Fundamental Data Overview January 12, 2026
P/E Forward = 75.7576
P/S = 7.8051
P/B = 8.1846
P/EG = 0.5738
Beta = 3.569
Revenue TTM = 3.46b USD
EBIT TTM = 674.1m USD
EBITDA TTM = 917.8m USD
Long Term Debt = 7.93b USD (from longTermDebt, last quarter)
Short Term Debt = 12.3m USD (from shortTermDebt, last quarter)
Debt = 7.96b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.53b USD (from netDebt column, last quarter)
Enterprise Value = 33.48b USD (27.00b + Debt 7.96b - CCE 1.48b)
Interest Coverage Ratio = 1.56 (Ebit TTM 674.1m / Interest Expense TTM 431.3m)
EV/FCF = 43.53x (Enterprise Value 33.48b / FCF TTM 769.2m)
FCF Yield = 2.30% (FCF TTM 769.2m / Enterprise Value 33.48b)
FCF Margin = 22.24% (FCF TTM 769.2m / Revenue TTM 3.46b)
Net Margin = 6.74% (Net Income TTM 233.1m / Revenue TTM 3.46b)
Gross Margin = 67.62% ((Revenue TTM 3.46b - Cost of Revenue TTM 1.12b) / Revenue TTM)
Gross Margin QoQ = 67.65% (prev 67.72%)
Tobins Q-Ratio = 2.92 (Enterprise Value 33.48b / Total Assets 11.48b)
Interest Expense / Debt = 1.38% (Interest Expense 110.0m / Debt 7.96b)
Taxrate = 2.80% (2.33m / 83.0m)
NOPAT = 655.2m (EBIT 674.1m * (1 - 2.80%))
Current Ratio = 14.61 (Total Current Assets 2.51b / Total Current Liabilities 171.7m)
Debt / Equity = 2.41 (Debt 7.96b / totalStockholderEquity, last quarter 3.30b)
Debt / EBITDA = 7.11 (Net Debt 6.53b / EBITDA 917.8m)
Debt / FCF = 8.49 (Net Debt 6.53b / FCF TTM 769.2m)
Total Stockholder Equity = 3.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.16% (Net Income 233.1m / Total Assets 11.48b)
RoE = 7.75% (Net Income TTM 233.1m / Total Stockholder Equity 3.01b)
RoCE = 6.16% (EBIT 674.1m / Capital Employed (Equity 3.01b + L.T.Debt 7.93b))
RoIC = 6.16% (NOPAT 655.2m / Invested Capital 10.64b)
WACC = 11.74% (E(27.00b)/V(34.96b) * Re(14.81%) + D(7.96b)/V(34.96b) * Rd(1.38%) * (1-Tc(0.03)))
Discount Rate = 14.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.41%
[DCF Debug] Terminal Value 55.45% ; FCFF base≈613.7m ; Y1≈402.9m ; Y5≈183.8m
Fair Price DCF = N/A (negative equity: EV 2.21b - Net Debt 6.53b = -4.32b; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 77.67 | EPS CAGR: 4.94% | SUE: -1.61 | # QB: 0
Revenue Correlation: 97.60 | Revenue CAGR: 28.83% | SUE: 0.55 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.73 | Chg30d=+0.000 | Revisions Net=+2 | Analysts=5
EPS current Year (2026-06-30): EPS=3.08 | Chg30d=-0.029 | Revisions Net=+4 | Growth EPS=+76.5% | Growth Revenue=+26.1%
EPS next Year (2027-06-30): EPS=3.81 | Chg30d=-0.022 | Revisions Net=+2 | Growth EPS=+23.5% | Growth Revenue=+24.8%
Additional Sources for AFRM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle